Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Sorter
Keyphrases
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
100%
Glioblastoma
100%
AE105
100%
PET Biomarkers
100%
Gallium-68
46%
Tumor
13%
Autoradiography
13%
Immunohistochemistry
6%
Risk Stratification
6%
Treatment Monitoring
6%
Tumor Growth
6%
High-level Expression
6%
Receptor Expression
6%
MRI Scan
6%
Brain Tissue
6%
Overall Survival
6%
Cancer Cells
6%
Inoculation
6%
Positron Emission Tomography-computed Tomography (PET-CT)
6%
PET Imaging
6%
Small Animal PET
6%
Imaging Biomarkers
6%
Image Contrast
6%
Fluorothymidine
6%
Specific Activity
6%
Glioma
6%
Human Cancer
6%
Messenger RNA Expression
6%
Radiochemical Purity
6%
PET Ligands
6%
Risk Treatment
6%
Tumor Expression
6%
Translational Studies
6%
Tyrosine
6%
Hematoxylin
6%
Eosin
6%
Tumor Location
6%
Cell Culture-derived
6%
Patient Tumor
6%
Tumor-to-background Ratio
6%
Receptor Specificity
6%
Injected Dose
6%
Activity Distribution
6%
Bioluminescence Imaging
6%
Tumor Detection
6%
FET-PET
6%
Tumor Delineation
6%
Clinical Exploration
6%
Molecular Imaging Biomarker
6%
Orthotopic Xenograft Model
6%
Medicine and Dentistry
Biological Marker
100%
Urokinase Receptor
100%
Positron Emission Tomography
100%
Glioblastoma
100%
Neoplasm
63%
Autoradiograph
18%
Malignant Neoplasm
9%
Risk Stratification
9%
Magnetic Resonance Imaging
9%
Immunohistochemistry
9%
Receptor Expression
9%
Haematoxylin
9%
Eosin
9%
Cancer Cell
9%
Overall Survival
9%
Positron Emission Tomography
9%
Positron Emission Tomography-Computed Tomography
9%
Molecular Imaging
9%
Cell Culture
9%
Ganglioglioma
9%
Tumor Progression
9%
Xenograft
9%
Patient Monitoring
9%
Brain Tissue
9%
Bioluminescence
9%
Tyrosine
9%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Urokinase Receptor
100%
Glioblastoma
100%
Neoplasm
63%
Malignant Neoplasm
18%
Mouse
18%
Autoradiography
18%
Overall Survival
9%
Cell Culture
9%
Haematoxylin
9%
Eosin
9%
Tumor Growth
9%
Tyrosine
9%
Neuroscience
Positron Emission Tomography
100%
Urokinase Receptor
100%
Autoradiograph
18%
Positron Emission Tomography
9%
Magnetic Resonance Imaging
9%
Immunohistochemistry
9%
Receptor Expression
9%
Cell Culture
9%
Molecular Imaging
9%
Haematoxylin
9%
Positron Emission Tomography-Computed Tomography
9%
Tyrosine
9%
Bioluminescence
9%